Skip to main content

Trexquant Investment LP

Position in NBIX — Neurocrine Biosciences Inc

CIK 1633445 STAMFORD, CT

Position in NBIX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$24,149,259
+$4,692,169 QoQ
Shares Held
183,310
+33.6% QoQ
Ownership
0.182%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2020
16 quarters on record
Voting authority Sole 91.03704107795537.ToString("F0")% Shared 0.ToString("F0")% None 8.962958922044624.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Trexquant Investment LP holds $120,085,995 across 26 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (20.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NBIX
Neurocrine Biosciences Inc
This page
183,310 $24,149,259

All Filings in NBIX

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $24,149,259 183,310
2025-12-31 $19,457,090 137,186
2025-09-30 $4,456,363 31,745
2025-03-31 $4,483,945 40,542
2024-12-31 $7,669,389 56,186
2024-09-30 $11,446,991 99,349
2024-03-31 $5,229,650 37,918
2023-12-31 $11,615,961 88,160
2023-09-30 $677,362 6,021
2023-03-31 $5,948,598 58,769
2022-12-31 $6,658,421 55,747
2022-09-30 $619,841 5,836
2021-12-31 $2,102,080 24,681
2021-06-30 $807,172 8,294
2020-12-31 $698,075 7,283
2020-09-30 $2,571,799 26,745